(Total Views: 564)
Posted On: 10/22/2020 10:53:27 AM
Post# of 149428
“NIce SeeWhy, Gild out.”
I wouldn’t discount GILD and remdesevir until the EUA is rescinded.
That doesn’t seem likely unless a gold standard study demonstrates no efficacy from the drug across any COVID population. GILD played their BP cards to get the EUA and they will not lose that EUA without a fight. Until then it’s the SO.
it’s also hard to gauge whether a majority of providers who treat COVID19 patients are going to discontinue use of Remdesevir because of the WHO findings. They don’t limited options at this point.
I wouldn’t discount GILD and remdesevir until the EUA is rescinded.
That doesn’t seem likely unless a gold standard study demonstrates no efficacy from the drug across any COVID population. GILD played their BP cards to get the EUA and they will not lose that EUA without a fight. Until then it’s the SO.
it’s also hard to gauge whether a majority of providers who treat COVID19 patients are going to discontinue use of Remdesevir because of the WHO findings. They don’t limited options at this point.
(0)
(0)Scroll down for more posts ▼
